Alammar, H.; Nassani, R.; Alshehri, M.M.; Aljohani, A.A.; Alrfaei, B.M.
Deficiency in the Treatment Description of mTOR Inhibitor Resistance in Medulloblastoma, a Systematic Review. Int. J. Mol. Sci. 2022, 23, 464.
https://doi.org/10.3390/ijms23010464
AMA Style
Alammar H, Nassani R, Alshehri MM, Aljohani AA, Alrfaei BM.
Deficiency in the Treatment Description of mTOR Inhibitor Resistance in Medulloblastoma, a Systematic Review. International Journal of Molecular Sciences. 2022; 23(1):464.
https://doi.org/10.3390/ijms23010464
Chicago/Turabian Style
Alammar, Hajar, Rayan Nassani, Mana M. Alshehri, Alaa A. Aljohani, and Bahauddeen M. Alrfaei.
2022. "Deficiency in the Treatment Description of mTOR Inhibitor Resistance in Medulloblastoma, a Systematic Review" International Journal of Molecular Sciences 23, no. 1: 464.
https://doi.org/10.3390/ijms23010464
APA Style
Alammar, H., Nassani, R., Alshehri, M. M., Aljohani, A. A., & Alrfaei, B. M.
(2022). Deficiency in the Treatment Description of mTOR Inhibitor Resistance in Medulloblastoma, a Systematic Review. International Journal of Molecular Sciences, 23(1), 464.
https://doi.org/10.3390/ijms23010464